Zydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...

In a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

A groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...

Private hospitals in India are feeling the pinch as government health schemes yield diminishing returns. This downturn provokes a critical ...

Dheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...

Gilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...

Local drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...

Corcept Therapeutics shares surged after the FDA approved its drug, Lifyorli, for a tough ovarian cancer. This new therapy, combined with c...

Researchers have redesigned a common chemotherapy drug into a spherical nucleic acid (SNA), dramatically increasing its potency by 20,000 t...

India's drug regulatory authority has instructed state-level counterparts to mandate manufacturers of Olaparib tablets in 100 mg and 150 mg...

Chemotherapy for decades was considered “the rule, the dogma,” for treating cancer, but various data offer some confirmation that the metho...

The device absorbs excess chemotherapy drugs before they spread throughout the body.

The company has received final approval from the US Food and Drug Administration (USFDA) to market the drug, Zydus Cadila said in a regulat...

With the technology of implanted ports aimed at increasing the ease of patients fast developing, such ports are being seen to minimise impa...

Meera Sachdeva was sentenced to 20 years in federal prison on charges that she defrauded Medicare by submitting false claims for chemothera...

Dabur Pharma says it has received a final approval from the US Food and Drug Administration for its chemotherapy drug Epirubicin injection.